Novel nanopore sequencing technology used to sequence long reads of over 100 cancer tumours from 100,000 Genomes Project
Findings show benefits of long-read sequencing where structural changes in genome can be spotted more easily.
The study is proof-of-concept for Genomics England to build analytical pipeline for long-read sequencing to be used alongside existing short-read sequencing technology to support clinical decisions.
This innovative research once again demonstrates the UK’s leadership in trialling cutting-edge technology to help improve the diagnosis and treatment of cancer, and successfully collaborate with industry experts beyond the pandemic, including Oxford Nanopore.
Cambridge Filmworks have partnered with Genomics England to produce a suite of new films to showcase their cutting edge work at the forefront of genomics medicine, using brand new techniques to find more precise ways to diagnose and improve the way we treat illness.
To find out more about Genomics England's pioneering work please visit: https://www.cambridgefilmworks.com/genomics-england/
